Patent dispute on Ultracet seen intensifying

Published: 2007-11-15 06:59:00

Updated: 2007-11-15 06:59:00

With 10 local pharmaceutical firms filing their nullification trial over Ultracet (tramadol HCl + acetaminophen) of Janssen Korea, Hanmi Pharm has also followed the suit with its revised patent on November 8.

Ultracet is indicated for the relief of moderate to severe pain in addition to the s...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK